• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Conatus Pharmaceuticals Inc. (CNAT)

    -NasdaqGM
    4.05 Up 0.37(10.05%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.68
    Open:3.64
    Bid:3.57 x 100
    Ask:7.15 x 200
    1y Target Est:13.00
    Beta:-0.589206
    Earnings Date:Nov 10 - Nov 16 (Est.)
    Day's Range:3.64 - 4.15
    52wk Range:3.44 - 11.74
    Volume:112,616
    Avg Vol (3m):173,188
    Market Cap:79.86M
    P/E (ttm):N/A
    EPS (ttm):-1.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CNAT

    Comparison

    Symbol% ChgMkt Cap
    CNATUp 10.05%79.86M
    ICPTDown 0.21%4.57B
    GALTUp 5.38%44.67M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.61
    Quarterly EPS Est (Sep-15) :-0.38
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-2.29

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback